Sponsor or institution
Clinical trials and research at Trethera Corporation
As of November 12, 2026, Find a Trial lists 7 NIH-funded research projects at this institution, with $6.0 million in listed awards. Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 7NIH research projects
NIH-funded research (7)
Early-stage science funded by the US National Institutes of Health. Most of these projects don't enroll patients, but they show what is being worked on.
-
Targeted small molecule to block cancer cell recovery and boost prostate cancer treatment
A new drug idea (TRE-515) aims to block cancer cells’ escape route after radiation to improve prostate cancer treatment.
-
New targeted pill for systemic lupus to slow flare activity
A patient-friendly look at a new oral drug that aims to block a cell process involved in lupus flares to help people with the disease feel better.
-
Targeted pill that blocks an immune-cell enzyme to ease Crohn's disease
This work is developing a new pill called TRE-515 that blocks an enzyme in immune cells to lower gut inflammation in people with Crohn's disease.
-
A new medicine for acute disseminated encephalomyelitis (ADEM)
This project is developing a new medicine to help children and adults with acute disseminated encephalomyelitis, a serious autoimmune disease affecting the brain and spinal cord.
-
New treatment for optic neuritis using a targeted small molecule inhibitor
This study is testing a new medication called TRE-515 to help people with optic neuritis, a condition that can cause vision problems, by targeting certain immune cells to reduce inflammation and improve vision.
-
New treatment for a serious brain disease affecting children
This study is testing a new drug called TRE-515 to see if it can help children with a serious condition called acute disseminated encephalomyelitis (ADEM) by reducing symptoms and helping them recover better than current treatments, which can have tough side effects.
-
New treatment for a serious brain condition called ADEM
This study is testing a new drug called TRE-515 to help children with a serious condition called acute disseminated encephalomyelitis (ADEM) by blocking a specific enzyme that causes harmful immune responses, with the hope of improving their recovery.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.